Page 131 - 2026 SMOG
P. 131

HEPARIN
                              Class/Mechanism of Action
         •  Anticoagulant
           Inactivates thrombin and activated coagulation factors (IX, X, XI, XII, and plasmin) and prevents
           conversion of fibrinogen to fibrin.
                                    Indications
         •  Labeled Indications
             Treatment of thromboembolic disorders
         •     ˚ Off-Label Indications
              ˚  ST elevation MI (STEMI) as an adjunct to thrombolysis; unstable angina/non-STEMI
                                  Contraindications
         •  Hypersensitivity to heparin or any component of the formulation (unless a life-threatening situation
           necessitates use and an alternative anticoagulant is not available)
         •  Uncontrolled active bleeding (except when caused by disseminated intravascular coagulation)
         •  Severe thrombocytopenia (low platelet level); history of heparin-induced thrombocytopenia
         •  Not for use when appropriate blood coagulation tests cannot be obtained at appropriate intervals
                            Adverse Reactions/Precautions
         •  Continuously monitor for bleeding; Stop immediately if any bleeding occurs
         •  Urticarial reactions and anaphylaxis can occur
         •  Heparin-induced thrombocytopenia (HIT) may occur during heparin therapy. Discontinue therapy as HIT
           can be fatal without treatment.
         •  Pregnancy: Safe
         •  Lactation: Safe, use preservative-free formulation
                                Dose/Administration
                                                    PEDIATRIC
                      ADULT
                                              (Always reference Broselow Tape)
         Acute Coronary Syndromes: STEMI/Unstable   Treatment of Venous Thromboembolism
         Angina as an Adjunct to Fibrinolysis (Full Dose   (Off-Label)
         Alteplase)                      •  IV
         •  IV                               Infants: Initial loading dose: 75units/kg over
             Initial: 60units/kg bolus (max: 4000 units)    ˚ 10min; then initial continuous maintenance
              ˚ Continuous maintenance infusion:    infusion at 28units/kg/hr
              ˚ 12units/kg/hr (max: 1000 units/hr)  Children and Adolescents: Initial loading
         Arterial Occlusion                   ˚ dose: 75units/kg over 10min, then initial
         •  IV                               continuous maintenance infusion at
             60–80units/kg; followed by continuous   20units/kg/hr
              ˚ 12–18units/kg/hr. Adjust the infusion rate to
             maintain the coagulation rate
         Treatment of Venous Thromboembolism
         (Off-Label)
         •  SubQ
             5000 units q8hr
              ˚ Should be considered prior to aeromedical
              ˚ evacuation for KNOWN VTE
         COVID VTE Prophylaxis
         •  SubQ
              ˚  7500 units q8hr
         Note: Heparin is ONLY for use under the written
         direction of the referring provider or direct
         consultation with the medical director
                          2026 Standard Medical Operating Guidelines (SMOG)  •   123
   126   127   128   129   130   131   132   133   134   135   136